Strategic Equity Capital plc · LSE:SEC

Strategic Equity Capital — Q1 2020 Earnings Presentation

32 slides from Strategic Equity Capital's earnings presentation, 2020

  1. Slide 1: Strategic Equity Capital plc Q1 Update 2020

    STRATEGIC EQUITY CAPITAL PLC Q1 Update 2020

  2. Slide 2: Risk considerations

    Risk considerations Risk Factors for Strategic Equity Capital plc (the Company”) – The general risk factors set out under the heading “D.1.Key Risks” of the Prospectus apply to the Company. In addition, potential investors should note the following factors: • There can be no guarantee that the inves

  3. Slide 3: Notice to recipients

    Notice to recipients This document is given to the recipient on condition that the recipient accepts that it is not a client of GVQ Investment Management Limited (“GVQIM”) and that hence, none of the client protections applicable to GVQIM’s clients are in fact in force or available, and GVQIM is not

  4. Slide 4: Contents

    Contents Q1 Update 2020 • Executive Summary 6 • Performance 7 • Detailed portfolio analysis 8 Outlook 18 Conclusion 23 Appendix 25 4

  5. Slide 5: Q1 Update 2020

    Q1 UPDATE 2020

  6. Slide 6: Executive summary

    Executive summary • SEC (the “Trust”) net assets per share decreased by 25,1%¹ over Q1. The FTSE Small Cap ex IT index (the “index”) decreased by 32.4%¹ • The quarter has been dominated by the ongoing Covid-19 pandemic which continues to have a severe impact on individuals, businesses and, of course

  7. Slide 7: Fund performance

    Fund performance Annualised 15 10 8.6 5 3.5 1.8 0 -1.0 -5 -2.9 -10 -6.7 -9.2 -15 -15.6 -20 -25 -24.4 -22.9 -25.1 -30 -35 -32.4 3 months 1 year 7 Feb 2017* 3 years 5 years 7 years SEC NAV Total Return FTSE Small Cap x IT Total Return Average 6.0% 6.8% 7.8% 7.6% 9.1% 9.6% Net Cash Consistent investmen

  8. Slide 8: Q1 Attribution analysis

    Q1 Attribution analysis Positive attribution bps GVQIM Comment Recommended takeover approach by Clayton, Dubiller & Rice at a 50% premium. A relatively recent Huntsworth 82 investment. On full realisation an IRR of 76% Acquired Ashfield Pharmacovigilance to strengthen US presence. Very strong full y

  9. Slide 9: Response to Covid-19

    Response to Covid-19 • Not panicked. Times of distress can lead to unhelpful cognitive behaviours • Retained a strong cash balance (c.10% of NAV). In early March, fully realised positions in Oxford Metrics (34% IRR) and Huntsworth (76% IRR) post take-over approach to supplement cash position • Portf

  10. Slide 10: Portfolio Characterisation – Covid-19

    Portfolio Characterisation – Covid-19 Resilient More operationally impacted Potential requiring action • Financially secure • Operational impact on demand • More direct impact of ‘shutdown’ and supply side • Sectors largely immune to direct • Fundamentally quality businesses impacts of restrictions

  11. Slide 11: Portfolio overview – Covid-19

    Portfolio overview – Covid-19 Company Weight (%) Impact assessment Business has a very high degree of ‘secured’ revenue. However, interest rate cuts , dividend suspensions and Equiniti 11.9 lower capital markets (M&A, IPO) activity will impact profitability , this is partially mitigated by elevated

  12. Slide 12: Higher potential risk / higher potential reward

    Pipeline considerations • Extraordinary environment gives rise to a number of investment opportunities that we are currently tracking 1. ‘Good businesses on sale’ • Many small cap share price moves have been extreme; however the impact of Covid on some sectors and businesses has also been extreme. S

  13. Slide 13: Potential macro economic implications

    Potential macro economic implications The situation is clearly uncertain and unprecedented. Economists and commentators are speculating over the length of the crisis and ‘shape’ of the recovery (‘U’, ‘tick’, ‘deep square root’). The following are some of the likely impacts of the current situation:

  14. Slide 14: Top holdings – Investment theses

    Top 10 holdings1 – Investment theses % of Company Sector Investment thesis portfolio High quality market leader in defensive and structurally growing share services and regulation technology markets. Ability to grow Support through demonstrable cross-sell, penetrating the North American market and t

  15. Slide 15: Oxford Metrics Group – portfolio realisation case study

    Oxford Metrics Group – portfolio realisation case study Position exited over Q4 2019 1.40 and Q1 2020. Final sale early • Oxford Metrics PLC (ticker: OMG-LN) focuses on developing and March 2020 at 112p Strategic update leads to increased commercialising image processing and location data technologi

  16. Slide 16: Highly concentrated and unconstrained portfolio

    Highly concentrated and unconstrained portfolio 9 Sector exposure by value 1 2 Value by market cap band 7 8 7 1 1 Healthcare 27.8% 1 <£50m 0.8% 6 2 Support services 16.5% 3 2 £50m - £100m 8.0% 3 Technology 15.0% 6 3 £100m - £200m 26.2% 5 4 Financials 12.4% 4 £200m - £300m 13.7% 2 5 Industrials 8.7%

  17. Slide 17: Portfolio valuation

    Portfolio valuation1 SEC SEC FTSE UK Small Cap ex weighted average median investment trusts Number of securities 21 21 146 Market cap (£m) 348 224 204 Consensus EV/EBITDA FY1 8.7x 7.9x 5.2x Consensus price earnings FY1 11.1x 10.4x 7.5x Consensus FY1 earnings growth 3.4% 1.5% 5.4% Consensus dividend

  18. Slide 18: Outlook

    OUTLOOK

  19. Slide 19: The current market crash in historical context

    The current market crash in historical context 20% 10% 0% -10% -20% -30% -40% -50% 0 1 2 3 4 6 7 8 9 10 11 2000 TMT bubble 2008 Financial Crisis Covid-19 The speed of the COVID-19 sell-off surpassed the Dot-Com bubble bursting and the 2008 crash. We are cautious over the timing of a sustainable reco

  20. Slide 20: UK vs. MSCI World valuation premium over time

    UK vs. MSCI World valuation premium over time 0% -5% -10% -15% -20% -25% -30% -35% -40% -45% 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 UK vs World valuation discount Average discount Notes: Latest available data Sources: Bloomberg/MSCI UK and World indices, average o

  21. Slide 21: Global private equity dry powder levels at record highs

    Global private equity dry powder levels were at record highs coming in to 2020 Total Private Equity Dry Powder, 2010 - 2019 HY bond yields over time (Bloomberg global high yield bond index) $1,600bn 25% $1,400bn 20% $1,200bn $1,000bn 15% $800bn $600bn 10% $400bn $200bn 5% $0bn 2010 2011 2012 2013 20

  22. Slide 22: Earnings growth, cashflow and M&A to drive returns

    Earnings growth, cashflow and M&A to drive returns SEC portfolio • A proportion of portfolio company • Private Equity ‘dry powder’ at record earnings impacted in the short term. levels. Likely that over time this will Longer term, growth driven by take advantage of very low public structural as oppo

  23. Slide 23: Conclusion

    CONCLUSION

  24. Slide 24: Conclusion

    Conclusion • SEC (the “Trust”) net assets per share decreased by 25,1%¹ over Q1. The FTSE Small Cap ex IT index (the “index”) decreased by 32.4%¹. The quarter has been dominated by the ongoing Covid-19 pandemic which continues to have a severe impact on individuals, businesses and, of course, financ

  25. Slide 25: Appendix

    APPENDIX

  26. Slide 26: Morningstar small cap investment trust overlap analysis

    Morningstar small cap investment trust overlap analysis ASL BRSC THRG GHS HSL IPU JMI MINI MTU SLS SEC ASL 9% 3% 0% 15% 13% 13% 1% 3% 4% 2% BRSC 9% 56% 0% 30% 21% 32% 1% 23% 30% 2% THRG 3% 56% 1% 23% 18% 25% 2% 29% 31% 1% GHS 0% 0% 1% 0% 0% 1% 0% 0% 0% 0% HSL 15% 30% 23% 0% 27% 27% 0% 13% 19% 4% IPU

  27. Slide 27: How we identify value in potential investments

    How we identify value in potential investments Main focus of most Main focus of most PUBLIC EQUITY INVESTORS PRIVATE EQUITY INVESTORS All investments undergo All investments are valued in-house, prospective using an in house cash-flow and historic leveraged buy-out model modelling Focus on recent re

  28. Slide 28: Research Committee ensures consistency of approach

    Research Committee ensures consistency of approach Preliminary Investment Final Investment Monitoring Idea generation Investment Memorandum Recommendation & review Recommendation Materials • Watch list • Company description • Company meeting • Counterparty analysis • Progress against • M&A transacti

  29. Slide 29: ESG Considerations

    ESG Considerations Strategy Portfolio • UK small cap universe is large and diverse; many high • Our analysis of the portfolio’s current holdings has quality, well managed, focused / niche companies exist not identified any significant ESG concerns in our • Concentrated portfolio enables high degree

  30. Slide 30: IFG Group – takeover case-study

    IFG Group – takeover case-study 2.00 Company announces proposed sale of Saunderson • On 25 March 2019, a recommended cash offer was made by Epiris House and potential Elysian Fuels liability Funds at 193p, a 46% premium to the closing share price, a trailing 1.90 PE valuation of 21.4x. SEC owned 9.9

  31. Slide 31: Long term track record

    Long term track record CAGR¹ Cumulative rebased total returns1 SEC NAV 15.2% 320 300 280 260 240 220 200 FTSE Small Cap ex IT 8.4% 180 160 140 120 100 80 60 40 Jun 09 Dec 10 Jun 12 Dec 13 Jun 15 Dec 16 Jun 18 Dec 19 Strong cumulative performance since process improvements in June 2009. No use of gea

  32. Slide 32: Contact details

    Contact details For further information regarding the SEC please contact the GVQ Investment Management marketing team below, or visit the Company’s website: www.strategicequitycapital.com For general enquiries, please contact: GVQ Investment Management Limited 16 Berkeley Street, London, W1J 8DZ Tel

Strategic Equity Capital — Q1 2020 Earnings Presentation on 6ix